Clinical Trials Directory

Trials / Completed

CompletedNCT02215655

Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hyperphosphatemia in end-stage renal disease (ESRD) patients is a non-traditional risk factor for all-cause and cardiovascular mortality. Non-adherence to phosphate binders is as high as 74% in ESRD patients and has been shown to be most related to psychosocial factors including attitudes. There is limited data on the influence of attitudes and perceived autonomy support on phosphate binder adherence and these two psychosocial constructs can be positively influenced through the use of motivational interviewing skills to increase autonomous motivation. Furthermore, racial disparities are known to exist in ESRD however and there are still gaps, which exist in understanding the determinants of disparities in adherence in vulnerable patients with ESRD. In this study, the investigators seek to determine the impact of motivational interviewing on phosphate binder adherence in diverse ESRD patients. The investigators will ask all the subjects to fill out surveys mainly regarding their attitudes; perceived providers' autonomy support and phosphate binder adherence. The investigators will administer motivational counseling to subjects in the intervention arm of the study, at baseline and 1 month after recruitment. The investigators will ask all the subjects to fill out the same surveys 2 months after recruitment and the investigators will compare subjects who underwent motivational interviewing to those who did not.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMotivational interviewingMotivational interviewing counselling sessions will be administered to the subjects.

Timeline

Start date
2014-09-01
Primary completion
2015-04-01
Completion
2015-05-01
First posted
2014-08-13
Last updated
2016-04-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02215655. Inclusion in this directory is not an endorsement.